PALB2 and breast cancer: Healthy individuals >25 years old carrying pathogenic/likely pathogenic variants in BRCA genes (+/− other hereditary genes like TP53 and PALB2) should undergo BC surveillance with monthly self-examinations, twice-a–year clinical breast examinations, and yearly mammograms (or MRI between age 25 and 35 years if resources permit).